116 related articles for article (PubMed ID: 33216966)
1. Implications of detecting serum monoclonal protein by MASS-fix following stem cell transplantation in multiple myeloma.
Abeykoon JP; Murray DL; Murray I; Jevremovic D; Otteson GE; Dispenzieri A; Arendt BK; Dasari S; Gertz M; Gonsalves WI; Kourelis TV; Muchtar E; Dingli D; Warsame R; Go RS; Lacy MQ; Leung N; Buadi F; Lin Y; Kyle RA; Rajkumar V; Kumar S; Kapoor P
Br J Haematol; 2021 Apr; 193(2):380-385. PubMed ID: 33216966
[TBL] [Abstract][Full Text] [Related]
2. Monitoring Minimal Residual Disease in Patients with Multiple Myeloma by Targeted Tracking Serum M-Protein Using Mass Spectrometry (EasyM).
Fan H; Wang B; Shi L; Pan N; Yan W; Xu J; Gong L; Li L; Liu Y; Du C; Cui J; Zhu G; Deng S; Sui W; Xu Y; Yi S; Hao M; Zou D; Chen X; Qiu L; An G
Clin Cancer Res; 2024 Mar; 30(6):1131-1142. PubMed ID: 38170583
[TBL] [Abstract][Full Text] [Related]
3. M-protein detection by mass spectrometry for minimal residual disease in multiple myeloma.
Guan L; Su W; Zhong J; Qiu L
Clin Chim Acta; 2024 Jan; 552():117623. PubMed ID: 37924928
[TBL] [Abstract][Full Text] [Related]
4. Dynamic monitoring of myeloma minimal residual disease with targeted mass spectrometry.
Noori S; Wijnands C; Langerhorst P; Bonifay V; Stingl C; Touzeau C; Corre J; Perrot A; Moreau P; Caillon H; Luider TM; Dejoie T; Jacobs JFM; van Duijn MM
Blood Cancer J; 2023 Feb; 13(1):30. PubMed ID: 36828828
[No Abstract] [Full Text] [Related]
5. Correction: Value of bone marrow examination in determining response to therapy in patients with multiple myeloma in the context of mass spectrometry-based M-protein assessment.
Claveau JS; Murray DL; Dispenzieri A; Kapoor P; Binder M; Buadi F; Dingli D; Fonder A; Gertz M; Gonsalves W; Hayman S; Hobbs M; Hwa YL; Kourelis T; Lacy M; Leung N; Lin Y; Warsame R; Kyle RA; Rajkumar V; Kumar SK
Leukemia; 2024 Jun; ():. PubMed ID: 38886490
[No Abstract] [Full Text] [Related]
6. Focus on monoclonal antibodies targeting B-cell maturation antigen (BCMA) in multiple myeloma: update 2021.
Demel I; Bago JR; Hajek R; Jelinek T
Br J Haematol; 2021 May; 193(4):705-722. PubMed ID: 33216972
[TBL] [Abstract][Full Text] [Related]
7. DT-PACE/ESHAP chemotherapy regimens as salvage therapy for multiple myeloma prior to autologous stem cell transplantation.
Ainley L; Chavda SJ; Counsell N; Cheesman S; Newrick F; Horder J; Kyriakou C; Papanikolaou X; Sive J; Lee L; Wechalekar A; Mehta A; Popat R; Rabin N; Yong K
Br J Haematol; 2021 Feb; 192(3):e73-e77. PubMed ID: 33236352
[No Abstract] [Full Text] [Related]
8. Characterization and prognostic implication of delayed complete response in AL amyloidosis.
Muchtar E; Gertz MA; Kumar SK; Lacy MQ; Leung N; Buadi FK; Dingli D; Hayman SR; Go RS; Kapoor P; Gonsalves W; Kourelis TV; Warsame R; Lisa Hwa Y; Fonder A; Hobbs M; Russell S; Lust JA; Siddiqui M; Vincent Rajkumar S; Kyle RA; Dispenzieri A
Eur J Haematol; 2021 Mar; 106(3):354-361. PubMed ID: 33230879
[TBL] [Abstract][Full Text] [Related]
9. Renal outcome in patients with newly diagnosed multiple myeloma: results from the UK NCRI Myeloma XI trial.
Rana R; Cockwell P; Drayson M; Cook M; Pratt G; Cairns DA; Pawlyn C; Jackson G; Davies F; Morgan G; Pinney JH
Blood Adv; 2020 Nov; 4(22):5836-5845. PubMed ID: 33232472
[TBL] [Abstract][Full Text] [Related]
10. Myeloma-Modified Adipocytes Exhibit Metabolic Dysfunction and a Senescence-Associated Secretory Phenotype.
Fairfield H; Dudakovic A; Khatib CM; Farrell M; Costa S; Falank C; Hinge M; Murphy CS; DeMambro V; Pettitt JA; Lary CW; Driscoll HE; McDonald MM; Kassem M; Rosen C; Andersen TL; van Wijnen AJ; Jafari A; Reagan MR
Cancer Res; 2021 Feb; 81(3):634-647. PubMed ID: 33218968
[TBL] [Abstract][Full Text] [Related]
11. Persistent challenges with treating multiple myeloma early.
Goodman AM; Kim MS; Prasad V
Blood; 2021 Jan; 137(4):456-458. PubMed ID: 33236046
[TBL] [Abstract][Full Text] [Related]
12. The screening imperative for multiple myeloma.
Rajkumar SV
Nature; 2020 Nov; 587(7835):S63. PubMed ID: 33235369
[No Abstract] [Full Text] [Related]
13. How researchers are addressing the racial imbalance in multiple myeloma.
Willyard C
Nature; 2020 Nov; 587(7835):S64-S65. PubMed ID: 33239806
[No Abstract] [Full Text] [Related]
14. AL Amyloidosis: The Effect of Maintenance Therapy on Autologous Stem Cell Transplantation Outcomes.
Ozga M; Zhao Q; Benson D; Elder P; Williams N; Bumma N; Rosko A; Chaudhry M; Khan A; Devarakonda S; Kahwash R; Vallakati A; Campbell C; Parikh SV; Almaani S; Prosek J; Bittengle J; Pfund K; LoRusso S; Freimer M; Redder E; Efebera Y; Sharma N
J Clin Med; 2020 Nov; 9(11):. PubMed ID: 33238501
[TBL] [Abstract][Full Text] [Related]
15. Front-line daratumumab-VTd versus standard-of-care in ASCT-eligible multiple myeloma: matching-adjusted indirect comparison.
Moreau P; Hebraud B; Facon T; Leleu X; Hulin C; Hashim M; Hu Y; Caillot D; Benboubker L; Zweegman S; Merz M; Weisel K; Salwender H; Mai EK; Goldschmidt H; Bertsch U; Vanquickelberghe V; Kampfenkel T; Boer C; Krotneva S; Proskorovsky I; He J; Lam A; Lee C; Cote S; Sonneveld P
Immunotherapy; 2021 Feb; 13(2):143-154. PubMed ID: 33228440
[No Abstract] [Full Text] [Related]
16. Anakinra: efficacy in the management of fever during neutropenia and mucositis in autologous stem cell transplantation (AFFECT-2)-study protocol for a multicenter randomized double-blind placebo-controlled trial.
de Mooij CEM; van Groningen LFJ; de Haan AFJ; Biemond BJ; Bakker M; van der Velden WJFM; Blijlevens NMA
Trials; 2020 Nov; 21(1):948. PubMed ID: 33225965
[TBL] [Abstract][Full Text] [Related]
17. Physical activity is associated with less comorbidity, better treatment tolerance and improved response in patients with multiple myeloma undergoing stem cell transplantation.
Möller MD; Ihorst G; Pahl A; Scheubeck S; Barsch F; Dold SM; Bertz H; Arends J; Wäsch R; Engelhardt M
J Geriatr Oncol; 2021 May; 12(4):521-530. PubMed ID: 33223484
[TBL] [Abstract][Full Text] [Related]
18. Amyloid cast nephropathy with systemic AL amyloidosis.
Mizuno S; Kosukegawa H
Int J Hematol; 2021 Jan; 113(1):1-2. PubMed ID: 33222047
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
